OGN

Organon & Co (OGN)

About Organon & Co (OGN)

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

Details

Daily high

$9.78

Daily low

$9.21

Price at open

$9.25

52 Week High

$13.24

52 Week Low

$5.69

Market cap

2.4B

Dividend yield

0.86%

Volume

7.0M

Avg. volume

7.4M

P/E ratio

13.02

Organon & Co News